172 related articles for article (PubMed ID: 37371795)
1. Vitamin D Role in Childhood Mite Allergy and Allergen Immunotherapy (AIT).
Petrarca C; Viola D
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371795
[TBL] [Abstract][Full Text] [Related]
2. Is there a rationale for supplementing with vitamin D patients under treatment with allergen immunotherapy?
Di Gioacchino M; Petrarca C; Della Valle L; Mangifesta R; Santilli F
Ann Med; 2023 Dec; 55(1):2230864. PubMed ID: 37387214
[TBL] [Abstract][Full Text] [Related]
3. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.
Florido-López JF; Andreu-Balaguer C; Escudero C; Seoane-Rodríguez M; Hernández M; Navarro-Seisdedos LÁ; Torrecillas-Toro M; Anton-Girones M; Herrero-Lifona L; Brugaletta D; Macías J; Pineda R; Lara MÁ; López-Caballero J; Rojas MJ
World Allergy Organ J; 2020 Dec; 13(12):100487. PubMed ID: 33376572
[TBL] [Abstract][Full Text] [Related]
5. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma.
Jutel M; Brüggenjürgen B; Richter H; Vogelberg C
Allergy; 2020 Aug; 75(8):2050-2058. PubMed ID: 32080856
[TBL] [Abstract][Full Text] [Related]
6. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
[TBL] [Abstract][Full Text] [Related]
7. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice.
Petrarca C; Clemente E; Amato V; Gatta A; Cortese S; Lamolinara A; Rossi C; Zanotta S; Mistrello G; Paganelli R; Di Gioacchino M
Clin Mol Allergy; 2016; 14():7. PubMed ID: 27499704
[TBL] [Abstract][Full Text] [Related]
9. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
[TBL] [Abstract][Full Text] [Related]
10. Serum-specific IgE and allergen immunotherapy in allergic children.
Tosca M; Silvestri M; Accogli A; Rossi GA; Ciprandi G
Immunotherapy; 2014; 6(1):29-33. PubMed ID: 24341881
[TBL] [Abstract][Full Text] [Related]
11. Effect of baseline serum vitamin D level on symptom and medication scores of subcutaneous immunotherapy in children with mite allergy.
Jia X; Zheng H; Yan X; Dai H; Xiang Q
Front Pediatr; 2022; 10():1018549. PubMed ID: 36389357
[TBL] [Abstract][Full Text] [Related]
12. Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology - ASBAI.
Aarestrup FM; Taketomi EA; Santos Galvão CE; Gagete E; Nóbrega Machado Arruda AC; Alves GB; Véras de Araújo Gueiros Lira G; Gonçalves MR; Couto Miziara MG; Maranhão Casado SS; Curi SV; Rufino Pereira VA; Sales V; Solé D; de Paula Motta Rubini N; Cavalcanti Sarinho ES
World Allergy Organ J; 2022 Oct; 15(10):100697. PubMed ID: 36254179
[TBL] [Abstract][Full Text] [Related]
13. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA
Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy and Asthma in Children.
Tosca MA; Licari A; Olcese R; Marseglia G; Sacco O; Ciprandi G
Front Pediatr; 2018; 6():231. PubMed ID: 30186823
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mite allergen immunotherapy in allergic rhinitis and the immune synergistic effect on cross-allergens.
Zheng P; Liu X; Lin L; Wu H; Zhao X; Sun B
Immunotherapy; 2021 Nov; ():. PubMed ID: 34845913
[TBL] [Abstract][Full Text] [Related]
16. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
Front Immunol; 2021; 12():786738. PubMed ID: 35197963
[TBL] [Abstract][Full Text] [Related]
17. Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
Pfaar O; Gerth van Wijk R
Curr Treat Options Allergy; 2015; 2(1):1-9. PubMed ID: 25798370
[TBL] [Abstract][Full Text] [Related]
18. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
19. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
Ciprandi G; Tosca MA; Silvestri M
Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients.
Nittner-Marszalska M; Kopeć A; Foks-Ciekalska A; Lata A; Bogacz-Piaseczyńska A; Rosiek-Biegus M; Zajac M; Bożek A
Hum Vaccin Immunother; 2022 Dec; 18(7):2148815. PubMed ID: 36444880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
